+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Severe Acute Respiratory Syndrome"

From
COVID-19 Testing Markets, 2023 - Product Thumbnail Image

COVID-19 Testing Markets, 2023

  • Report
  • April 2023
  • 131 Pages
  • Global
From
Emerging Infectious Disease Market Trends, 2022 - Product Thumbnail Image

Emerging Infectious Disease Market Trends, 2022

  • Report
  • August 2022
  • 96 Pages
  • Global
From
In Vitro Diagnostics (IVD) in the Middle East and Africa - Product Thumbnail Image

In Vitro Diagnostics (IVD) in the Middle East and Africa

  • Report
  • May 2022
  • 102 Pages
  • Middle East, Africa
From
IVD Procedure Volumes 2021-2026 - Product Thumbnail Image

IVD Procedure Volumes 2021-2026

  • Report
  • March 2022
  • 312 Pages
  • Global
From
Lateral Flow Assays Market - Global Outlook & Forecast 2023-2028 - Product Thumbnail Image

Lateral Flow Assays Market - Global Outlook & Forecast 2023-2028

  • Report
  • February 2023
  • 312 Pages
  • Global
From
From
From
Global COVID-19 Diagnostics and Kits Market: 2020-2025 - Product Thumbnail Image

Global COVID-19 Diagnostics and Kits Market: 2020-2025

  • Report
  • April 2021
  • 145 Pages
  • Global
From
In Vitro Diagnostics: Technologies and Global Markets - Product Thumbnail Image

In Vitro Diagnostics: Technologies and Global Markets

  • Report
  • April 2021
  • 302 Pages
  • Global
From
Tissue Diagnostics: Technologies and Global Markets 2021-2026 - Product Thumbnail Image

Tissue Diagnostics: Technologies and Global Markets 2021-2026

  • Report
  • September 2021
  • 262 Pages
  • Global
From
From
Loading Indicator

Severe Acute Respiratory Syndrome (SARS) is a contagious respiratory illness caused by a virus. Diagnostics for SARS involve laboratory tests to detect the virus or its genetic material in a sample taken from the patient. Diagnostic tests for SARS include reverse transcription-polymerase chain reaction (RT-PCR), antigen-capture enzyme-linked immunosorbent assay (ELISA), and nucleic acid hybridization. These tests are used to detect the presence of the virus in a patient's sample and to differentiate between SARS and other respiratory illnesses. Diagnostics for SARS are important for early detection and treatment of the disease. Early diagnosis and treatment can reduce the severity of the illness and prevent its spread. Diagnostics for SARS are also used to monitor the spread of the virus and to track its evolution. Companies in the SARS diagnostics market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more